Joint Outcome Study

This study has been completed.
Information provided by:
Centers for Disease Control and Prevention Identifier:
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted

This study examines the progression of joint disease in children with hemophilia assigned to either standard treatment or enhanced therapy.

Hemophilia A

Study Type: Observational
Study Design: Observational Model: Natural History
Time Perspective: Longitudinal
Official Title: A Clinical Trial of Primary Prophylaxis Against Joint Disease in Children With Severe Hemophilia

Resource links provided by NLM:

Further study details as provided by Centers for Disease Control and Prevention:

Estimated Enrollment: 64
Study Start Date: September 1995
Estimated Study Completion Date: August 2005

Ages Eligible for Study:   1 Year to 30 Months
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Diagnosed with hemophilia A
  • factor level less than 2%

Exclusion Criteria:

  • More than 2 bleeds into the same joint
  Contacts and Locations
Please refer to this study by its identifier: NCT00207597

Sponsors and Collaborators
Principal Investigator: Marilyn J Manco-Johnson, MD University of Colorado, Denver
  More Information

No publications provided by Centers for Disease Control and Prevention

Additional publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00207597     History of Changes
Other Study ID Numbers: CDC-NCBDDD-1455, U27/CCU812106
Study First Received: September 13, 2005
Last Updated: September 13, 2005
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Hemophilia A
Blood Coagulation Disorders, Inherited
Blood Coagulation Disorders
Hematologic Diseases
Coagulation Protein Disorders
Hemorrhagic Disorders
Genetic Diseases, Inborn processed this record on April 16, 2014